New Micro-extrusion Advanced Technology for plant-based whole-cut meat substitutes
NOVAMEAT uses tissue engineering and 3D printing to create sustainable, plant-based whole-cut meat alternatives with diverse nutritional and sensory profiles, addressing overpopulation and climate issues.
Projectdetails
Introduction
Due to the current overpopulation, climate change, and aggressive animal farming problems, there is an urgent need for the next generation of alternative proteins meat.
Technology Development
Based on tissue engineering, food science, and 3D printing, NOVAMEAT has developed a micro-extrusion process that can bio-hack the native 3D network structure of molecules of plant origin. This process creates the microstructure and anisotropic morphology similar to that of traditional animal meat in a cost-efficient and highly scalable manner.
Unique Formulation
NOVAMEAT's advanced and unique technology results in pieces of whole-cuts meat composed of a patent-pending formulation of a natural-origin wide range of different vegetable proteins, fibers, oils, and aromas. This enables NewMEAT to achieve multiple varieties of nutritional, flavor, and texturization profiles akin to animal whole-cut meats.
Sustainability
NewMEAT does not contain soy but is composed of sustainable ingredients with a much lower environmental impact. This approach supports resilient agriculture and animal welfare.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 1.860.725 |
Totale projectbegroting | € 2.658.178 |
Tijdlijn
Startdatum | 1-1-2022 |
Einddatum | 31-12-2023 |
Subsidiejaar | 2022 |
Partners & Locaties
Projectpartners
- NOVAMEAT TECH SLpenvoerder
Land(en)
Vergelijkbare projecten binnen EIC Accelerator
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
A new cardioprotective drug for acute treatment of myocardial infarctionResoTher aims to validate RTP-026, an immunomodulating therapy, to reduce heart damage and HF risk post-myocardial infarction through Phase II clinical studies. | EIC Accelerator | € 2.499.999 | 2024 | Details |
Clear, scalable and scientific framework to measure terrestrial biodiversity3Bee leverages IoT, wildlife monitoring, and satellite data to measure and regenerate biodiversity, generating certified Biodiversity Credits for corporations to enhance ESG reporting and brand value. | EIC Accelerator | € 2.252.714 | 2024 | Details |
Novel and Scalable microbial products for REgenerative agricultureN-Spire aims to revolutionize agriculture by creating a sustainable bioactive fertilizer through innovative manufacturing techniques, enhancing soil health and reducing chemical dependency. | EIC Accelerator | € 2.499.999 | 2024 | Details |
Quantum-based Randomness Processing Units (RPUs) for High-Performance Computation and Data SecurityQuside's Randomness Processing Unit (RPU) accelerates stochastic HPC and PQ cryptography by optimizing random workloads, enhancing efficiency and performance across various sectors. | EIC Accelerator | € 2.499.999 | 2024 | Details |
A new cardioprotective drug for acute treatment of myocardial infarction
ResoTher aims to validate RTP-026, an immunomodulating therapy, to reduce heart damage and HF risk post-myocardial infarction through Phase II clinical studies.
Clear, scalable and scientific framework to measure terrestrial biodiversity
3Bee leverages IoT, wildlife monitoring, and satellite data to measure and regenerate biodiversity, generating certified Biodiversity Credits for corporations to enhance ESG reporting and brand value.
Novel and Scalable microbial products for REgenerative agriculture
N-Spire aims to revolutionize agriculture by creating a sustainable bioactive fertilizer through innovative manufacturing techniques, enhancing soil health and reducing chemical dependency.
Quantum-based Randomness Processing Units (RPUs) for High-Performance Computation and Data Security
Quside's Randomness Processing Unit (RPU) accelerates stochastic HPC and PQ cryptography by optimizing random workloads, enhancing efficiency and performance across various sectors.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
A Revolutionary Tech for Exceptionally Efficient Natural Muscle Tissue Growth in Cultivated Meat ApplicationsProFuse aims to optimize a novel myoblast cell line and media supplement to enhance the scalability and quality of cultivated meat, targeting TRL6 validation with potential clients. | EIC Transition | € 2.432.030 | 2024 | Details |
Volwaardige Vegan VleesvervangersRival Foods en FUL Foods ontwikkelen een nieuwe generatie vleesvervangers met verbeterde voedingswaarde en structuur, om de consumptie van vlees te verminderen en milieu-impact te verlagen. | MIT R&D Samenwerking | € 342.972 | 2022 | Details |
Plant-Based Protein: Vleesvervangers o.b.v. veldbonen-eiwitHet project richt zich op het ontwikkelen van een productieproces voor duurzame, lokaal geproduceerde plantaardige eiwitten om de consumptie van dierlijke eiwitten te verminderen. | MIT R&D Samenwerking | € 198.100 | 2019 | Details |
Productie van nieuwe vleesvervangers op basis van microbieel eiwitDalco Food en BioscienZ ontwikkelen een technologie voor de grootschalige productie van microbiële eiwitten uit groente- en fruitreststromen, gericht op efficiënte vleesvervangers en voedselveiligheid. | MIT R&D Samenwerking | € 113.663 | 2018 | Details |
A Revolutionary Tech for Exceptionally Efficient Natural Muscle Tissue Growth in Cultivated Meat Applications
ProFuse aims to optimize a novel myoblast cell line and media supplement to enhance the scalability and quality of cultivated meat, targeting TRL6 validation with potential clients.
Volwaardige Vegan Vleesvervangers
Rival Foods en FUL Foods ontwikkelen een nieuwe generatie vleesvervangers met verbeterde voedingswaarde en structuur, om de consumptie van vlees te verminderen en milieu-impact te verlagen.
Plant-Based Protein: Vleesvervangers o.b.v. veldbonen-eiwit
Het project richt zich op het ontwikkelen van een productieproces voor duurzame, lokaal geproduceerde plantaardige eiwitten om de consumptie van dierlijke eiwitten te verminderen.
Productie van nieuwe vleesvervangers op basis van microbieel eiwit
Dalco Food en BioscienZ ontwikkelen een technologie voor de grootschalige productie van microbiële eiwitten uit groente- en fruitreststromen, gericht op efficiënte vleesvervangers en voedselveiligheid.